Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Fielding

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
Blood|March 17, 2023
Iron homeostasis governs erythroid phenotype in polycythemia veraCavan Bennett, Victoria E Jackson, Anne Pettikiriarachchi, et al.
BMC Medicine|November 9, 2020
Risk scores for predicting early antiretroviral therapy mortality in sub-Saharan Africa to inform who needs intensification of care: a derivation and external validation cohort studyAndrew F Auld, Katherine Fielding, Tefera Agizew, et al.
Lancet (London, England)|March 14, 2025
Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis: four pragmatic, cluster-randomised trialsDegu Jerene, Kristian van Kalmthout, Jens Levy, et al.
The Lancet. HIV|February 9, 2026
Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trialJayne Ellis, Gila Hale, Laura J Nsangi, et al.
The Lancet. Global Health|January 27, 2019
Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysisGian Luca Di Tanna, Ali Raza Khaki, Grant Theron, et al.
The Lancet. HIV|March 26, 2022
Tuberculosis screening among HIV-positive inpatients: a systematic review and individual participant data meta-analysisAshar Dhana, Yohhei Hamada, Andre P Kengne, et al.
Medrxiv : the Preprint Server for Health Sciences|April 22, 2024
Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: an individual patient data meta-analysisSun Kim, Melike Hazal Can, Tefera B Agizew, et al.
Plos Medicine|January 13, 2025
Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysisSun Kim, Melike Hazal Can, Tefera B Agizew, et al.
The Lancet. Microbe|December 22, 2024
Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant dataPuck T Pelzer, Logan Stuck, Leonardo Martinez, et al.
NEJM Evidence|February 6, 2024
Four-Month High-Dose Rifampicin Regimens for Pulmonary TuberculosisAmina Jindani, Daniel Atwine, Daniel Grint, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
Blood|March 17, 2023
Iron homeostasis governs erythroid phenotype in polycythemia veraCavan Bennett, Victoria E Jackson, Anne Pettikiriarachchi, et al.
BMC Medicine|November 9, 2020
Risk scores for predicting early antiretroviral therapy mortality in sub-Saharan Africa to inform who needs intensification of care: a derivation and external validation cohort studyAndrew F Auld, Katherine Fielding, Tefera Agizew, et al.
Lancet (London, England)|March 14, 2025
Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis: four pragmatic, cluster-randomised trialsDegu Jerene, Kristian van Kalmthout, Jens Levy, et al.
The Lancet. HIV|February 9, 2026
Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trialJayne Ellis, Gila Hale, Laura J Nsangi, et al.
The Lancet. Global Health|January 27, 2019
Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysisGian Luca Di Tanna, Ali Raza Khaki, Grant Theron, et al.
The Lancet. HIV|March 26, 2022
Tuberculosis screening among HIV-positive inpatients: a systematic review and individual participant data meta-analysisAshar Dhana, Yohhei Hamada, Andre P Kengne, et al.
Medrxiv : the Preprint Server for Health Sciences|April 22, 2024
Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: an individual patient data meta-analysisSun Kim, Melike Hazal Can, Tefera B Agizew, et al.
Plos Medicine|January 13, 2025
Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysisSun Kim, Melike Hazal Can, Tefera B Agizew, et al.
The Lancet. Microbe|December 22, 2024
Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant dataPuck T Pelzer, Logan Stuck, Leonardo Martinez, et al.
NEJM Evidence|February 6, 2024
Four-Month High-Dose Rifampicin Regimens for Pulmonary TuberculosisAmina Jindani, Daniel Atwine, Daniel Grint, et al.
Pageof 20